ArticleBritish journal of pharmacology2019

A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.

Jin-Cherng Lien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.